Medical and hoarse bottles are seen with the Novo Nordisk logo on a background screen.
Norfuto Norfuto Gety pictures
Danish pharmaceutical giant Novo Nordsk On Wednesday, I reported a net profit for better than expected in the fourth quarter, amid the high demand for obesity drugs in Wegovy.
The net profit for the fourth quarter reached 28.23 billion Danish Kroner, compared to 26.09 billion kronor.
Drug maker post 107% Annual on the basis of Wegovy sales to 19.87 billion Danish Crohn ($ 2.76 billion) in the three months until the end of December, a 20.02 billion Danish Crohn's expectations were lost by analysts in the FactSet survey late Tuesday.
This is an urgent news story and will be updated soon.
